Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 100,415 | 100,415 | 0 | $30.39M | $46.06M | 7.54% | +$15.67M |
| Cullinan Therapeutics, Inc.(CGEM) | 7,648,268 | 7,648,268 | 0 | $57.59M | $45.35M | 7.42% | -$12.24M |
| Avidity Biosciences Inc | 760,022 | 760,022 | 0 | $21.58M | $33.11M | 5.42% | +$11.53M |
| Trevi Therapeutics, Inc.(TRVI) | 3,406,955 | 3,406,955 | 0 | $18.64M | $31.17M | 5.10% | +$12.54M |
| Edgewise Therapeutics, Inc.(EWTX) | 1,720,741 | 1,720,741 | 0 | $22.56M | $27.91M | 4.57% | +$5.35M |
| PTC Therapeutics, Inc.(PTCT) | 438,477 | 438,477 | 0 | $21.42M | $26.91M | 4.41% | +$5.49M |
| Zai Lab LimitedADR(ZLAB) | 745,060 | 745,060 | 0 | $26.05M | $25.25M | 4.13% | -$804.7K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 0 | 1,375,674 | +1,375,674 | $0 | $21.16M | 3.46% | +$21.16M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 1,729,378 | 1,729,378 | 0 | $17.55M | $20.75M | 3.40% | +$3.20M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 341,496 | 341,496 | 0 | $13.83M | $20.30M | 3.32% | +$6.46M |
| Xenon Pharmaceuticals Inc.(XENE) | 323,398 | 503,398 | +180,000 | $10.12M | $20.21M | 3.31% | +$10.09M |
| Stoke Therapeutics, Inc.(STOK) | 789,698 | 789,698 | 0 | $8.96M | $18.56M | 3.04% | +$9.59M |
| Dyne Therapeutics, Inc.(DYN) | 1,446,361 | 1,446,361 | 0 | $13.77M | $18.30M | 3.00% | +$4.53M |
| Compass Therapeutics, Inc.(CMPX) | 5,622,505 | 5,075,970 | -546,535 | $14.62M | $17.77M | 2.91% | +$3.15M |
| Alkermes plc(ALKS) | 549,262 | 549,262 | 0 | $15.71M | $16.48M | 2.70% | +$763.5K |
| Vera Therapeutics, Inc.CL A(VERA) | 563,075 | 563,075 | 0 | $13.27M | $16.36M | 2.68% | +$3.10M |
| Natera, Inc.(NTRA) | 98,924 | 98,924 | 0 | $16.71M | $15.92M | 2.61% | -$788.4K |
| Janux Therapeutics, Inc.(JANX) | 614,282 | 614,282 | 0 | $14.19M | $15.01M | 2.46% | +$823.1K |
| Revolution Medicines, Inc.(RVMD) | 315,722 | 315,722 | 0 | $11.62M | $14.74M | 2.41% | +$3.13M |
| Context Therapeutics Inc.(CNTX) | 14,705,882 | 14,705,882 | 0 | $9.64M | $14.25M | 2.33% | +$4.61M |
| Sarepta Therapeutics, Inc.(SRPT) | 321,696 | 700,000 | +378,304 | $5.50M | $13.49M | 2.21% | +$7.99M |
| ARS Pharmaceuticals, Inc.(SPRY) | 1,303,399 | 1,303,399 | 0 | $22.74M | $13.10M | 2.14% | -$9.65M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 3,903,081 | 3,903,381 | +300 | $9.56M | $12.73M | 2.08% | +$3.16M |
| Relay Therapeutics, Inc.(RLAY) | 2,282,680 | 2,282,680 | 0 | $7.90M | $11.92M | 1.95% | +$4.02M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 395,700 | 395,700 | 0 | $14.39M | $11.90M | 1.95% | -$2.48M |
| Wave Life Sciences, Inc.(WVE) | 1,505,262 | 1,505,262 | 0 | $9.78M | $11.02M | 1.80% | +$1.23M |
| DBV Technologies S.A.ADS(DBVT) | 1,054,504 | 1,054,504 | 0 | $9.65M | $10.55M | 1.73% | +$896.3K |
| Soleno Therapeutics Inc | 50,000 | 150,000 | +100,000 | $4.19M | $10.14M | 1.66% | +$5.95M |
| Solid Biosciences Inc | 1,634,569 | 1,634,569 | 0 | $7.96M | $10.09M | 1.65% | +$2.12M |
| Akebia Therapeutics, Inc.(AKBA) | 2,889,125 | 2,889,125 | 0 | $10.52M | $7.89M | 1.29% | -$2.63M |
| Werewolf Therapeutics, Inc.(HOWL) | 2,408,810 | 2,408,810 | 0 | $2.63M | $4.75M | 0.78% | +$2.12M |
| Liquidia Corporation(LQDA) | 0 | 200,000 | +200,000 | $0 | $4.55M | 0.74% | +$4.55M |
| Palvella Therapeutics, Inc.(PVLA) | 0 | 67,423 | +67,423 | $0 | $4.23M | 0.69% | +$4.23M |
| Design Therapeutics, Inc.(DSGN) | 555,187 | 555,187 | 0 | $1.87M | $4.18M | 0.68% | +$2.31M |
| Cartesian Therapeutics, Inc.(RNAC) | 686,007 | 380,000 | -306,007 | $7.13M | $3.88M | 0.64% | -$3.24M |
| enGene Holdings Inc COM | 0 | 530,299 | +530,299 | $0 | $3.62M | 0.59% | +$3.62M |
| UroGen Pharma Ltd.(URGN) | 0 | 135,000 | +135,000 | $0 | $2.69M | 0.44% | +$2.69M |
| Rapport Therapeutics, Inc.(RAPP) | 0 | 71,807 | +71,807 | $0 | $2.13M | 0.35% | +$2.13M |
| Repare Therapeutics, Inc. | 819,924 | 819,924 | 0 | $1.14M | $1.44M | 0.24% | +$303.4K |
| Assembly Biosciences Inc | 0 | 39,665 | +39,665 | $0 | $1.02M | 0.17% | +$1.02M |
| Arcellx Inc COMMON STOCK | 37 | 0 | -37 | $2.4K | $0 | — | -$2.4K |
| Adaptimmune Therapeutics plcADS(ADAPY) | 4,411,821 | 0 | -4,411,821 | $1.06M | $0 | — | -$1.06M |
| Crinetics Pharmaceuticals Inc. | 428,975 | 0 | -428,975 | $12.34M | $0 | — | -$12.34M |
| Guardant Health, Inc.(GH) | 442,656 | 0 | -442,656 | $23.04M | $0 | — | -$23.04M |
| MBX Biosciences, Inc.(MBX) | 1,294,416 | 0 | -1,294,416 | $14.77M | $0 | — | -$14.77M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 313,571 | 0 | -313,571 | $14.80M | $0 | — | -$14.80M |
| Nuvation Bio Inc.(NUVB) | 4,622,590 | 0 | -4,622,590 | $9.01M | $0 | — | -$9.01M |
| Olema Pharmaceuticals, Inc.(OLMA) | 2,378,762 | 0 | -2,378,762 | $10.13M | $0 | — | -$10.13M |
| Replimune Group, Inc.(REPL) | 983,780 | 0 | -983,780 | $9.14M | $0 | — | -$9.14M |
| Taysha Gene Therapies, Inc.(TSHA) | 2,953,562 | 0 | -2,953,562 | $6.82M | $0 | — | -$6.82M |
| Veru Inc.(VERU) | 4,911,948 | 0 | -4,911,948 | $2.86M | $0 | — | -$2.86M |